Skip to content

Dextromethorphan psychosis, dependence and physical withdrawal.

Shannon C Miller

Addiction biology December 1, 2005 DOI: 10.1080/13556210500352410 via PubMed

Summary

AI-generated from the abstract

Dextromethorphan (DM), an over-the-counter cough medicine available in over 140 preparations, can cause addiction, psychosis, and withdrawal when abused at greater than indicated doses. A case of DM dependence with rarely published complications is described, based on an interview with the individual and a review of medical databases. DM and its active metabolite dextrorphan (DOR) have specific biological features of addiction and can induce psychiatric sequelae. DOR has pharmacodynamic properties similar to dissociatives and may be more responsible for the dissociative effect sought by abusers, but also carries risks of life-threatening psychoses, dissociative-induced accidents, and addiction. Health-care providers appear largely unaware of DM's toxidrome and addiction liability.

Study at a glance

Characteristics Case study with literature review Case report Peer reviewed
Sample size 1
Population Individual with dextromethorphan dependence
Key finding Dextromethorphan abuse can cause substance dependence, substance-induced psychosis, and substance withdrawal, with its active metabolite dextrorphan contributing to dissociative effects and risks.

Abstract

As part of a synthesis of evidence regarding the abuse and addiction liability of dextromethorphan (DM), an over-the-counter cough medicine available in over 140 preparations, an uncommonly published case of dextromethorphan dependence (addiction) is described, with specific, rarely published complications. The individual was interviewed and several medical databases were also reviewed (Medline, 1966-present; PubMed) for all content relating to the Keywords: dextromethorphan, abuse, dependence, cough medicine, addiction, withdrawal, psychosis. The patient evidenced history suggesting substance dependence, substance-induced psychosis and substance withdrawal in relation to DM. A literature review revealed that DM has specific serotonergic and sigma-1 opioidergic properties. Dextrorphan (DOR), the active metabolite of DM, has similar properties; however, DOR is a weaker sigma opioid receptor agonist, and a stronger NMDA receptor antagonist. DM and DOR display specific biological features of addiction, and are capable of inducing specific psychiatric sequelae. A specific, reproducible toxidrome with significant psychiatric effects occurred, when DM was abused at greater than indicated doses, with more profound and potentially life-threatening effects at even higher doses. DM withdrawal appears evident. DM's active metabolite, DOR, has pharmacodynamic properties and intoxication effects similar to dissociatives, and may be more responsible for the dissociative effect that this DM abuser sought. However, it is this same metabolite that may be fraught with the potentially life-threatening psychoses and dissociative-induced accidents, as well as addiction. While DM has been hypothesized as the most commonly abused dissociative, health-care providers seem largely unaware of its toxidrome and addiction liability.

Comments

No comments yet.

Log in to comment